Citi Nears Long-Awaited China Brokerage Licence

Citigroup could receive final approval for its wholly owned China brokerage business as early as September, ending a regulatory wait that has stretched nearly five years. The licence would deepen Citi’s onshore securities presence at a time when global banks are reassessing how much capital and management attention China still warrants.

Citi applied for the brokerage licence in late 2021 as part of a broader push into China’s financial markets. Once approved, the unit is expected to offer A-share brokerage, underwriting, research and principal trading, putting it more directly against Wall Street rivals including JPMorgan, Goldman Sachs and Morgan Stanley. The bank also plans to double headcount at the business to about 100 by year-end, drawing staff from Hong Kong and elsewhere in Asia.

The timing is notable. Beijing has continued opening parts of its financial sector to foreign institutions despite wider tensions with Washington, giving international banks greater ownership and operating freedom. Yet the opportunity has become more selective. Fidelity International and Schroders have recently scaled back parts of their China operations, reflecting intense competition, weaker profitability and the difficulty of building scale against entrenched domestic players.

For Citi, the licence would add an onshore platform to an existing corporate and institutional banking franchise, creating more room to pursue equity, advisory and capital-markets mandates from Chinese clients. Technology, healthcare and financial institutions are expected to be key areas of focus.

The broader banking story is one of access meeting discipline. China remains too large for global banks to ignore, but market entry alone no longer guarantees returns. Citi’s next test will be whether a fuller securities presence can translate regulatory access into sustainable deal flow and profitability.